Why is Advanced Enzyme Technologies Ltd ?
1
The company is Net-Debt Free
2
Poor long term growth as Operating profit has grown by an annual rate -1.41% of over the last 5 years
3
Positive results in Mar 26
- PBT LESS OI(Q) At Rs 52.46 cr has Grown at 51.14%
- PAT(Q) At Rs 42.88 cr has Grown at 61.9%
- NET SALES(Q) At Rs 203.37 cr has Grown at 21.65%
4
With ROE of 9.8, it has a Very Expensive valuation with a 2.2 Price to Book Value
- The stock is trading at a fair value compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of 3.96%, its profits have risen by 22.3% ; the PEG ratio of the company is 1
5
High Institutional Holdings at 31.49%
- These investors have better capability and resources to analyse fundamentals of companies than most retail investors.
- Their stake has increased by 0.59% over the previous quarter.
How much should you hold?
- Overall Portfolio exposure to Advanced Enzyme should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Advanced Enzyme for you?
High Risk, Medium Return
Absolute
Risk Adjusted
Volatility
Advanced Enzyme
3.96%
0.10
37.97%
Sensex
-2.63%
-0.19
13.57%
Quality key factors
Factor
Value
Sales Growth (5y)
8.24%
EBIT Growth (5y)
-1.41%
EBIT to Interest (avg)
63.44
Debt to EBITDA (avg)
0.19
Net Debt to Equity (avg)
-0.41
Sales to Capital Employed (avg)
0.46
Tax Ratio
25.34%
Dividend Payout Ratio
44.37%
Pledged Shares
0
Institutional Holding
31.49%
ROCE (avg)
19.58%
ROE (avg)
9.95%
Valuation Key Factors 
Factor
Value
P/E Ratio
23
Industry P/E
44
Price to Book Value
2.23
EV to EBIT
15.72
EV to EBITDA
12.97
EV to Capital Employed
3.08
EV to Sales
3.98
PEG Ratio
1.02
Dividend Yield
0.41%
ROCE (Latest)
19.60%
ROE (Latest)
9.82%
Loading Valuation Snapshot...
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Mildly Bullish
Dow Theory
Mildly Bullish
Mildly Bearish
OBV
Mildly Bearish
Mildly Bearish
Technical Movement
4What is working for the Company
PAT(Latest six months)
At Rs 79.97 cr has Grown at 20.41%
-7What is not working for the Company
PBT LESS OI(Q)
At Rs 40.51 cr has Fallen at -12.03%
DEBTORS TURNOVER RATIO(HY)
Lowest at 5.14 times
OPERATING PROFIT TO NET SALES (Q)
Lowest at 26.86%
PAT(Q)
At Rs 37.09 cr has Fallen at -7.1%
EPS(Q)
Lowest at Rs 3.31
Loading Valuation Snapshot...
Here's what is not working for Advanced Enzyme
Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 40.51 cr has Fallen at -12.03%
Year on Year (YoY)MOJO Watch
Near term PBT trend is very negative
PBT less Other Income (Rs Cr)
Operating Profit Margin - Quarterly
Lowest at 26.86%
in the last five quartersMOJO Watch
Company's efficiency has deteriorated
Operating Profit to Sales
Profit After Tax (PAT) - Quarterly
At Rs 37.09 cr has Fallen at -7.1%
Year on Year (YoY)MOJO Watch
Near term PAT trend is negative
PAT (Rs Cr)
Earnings per Share (EPS) - Quarterly
Lowest at Rs 3.31
in the last five quartersMOJO Watch
Declining profitability; company has created lower earnings for shareholders
EPS (Rs)
Debtors Turnover Ratio- Half Yearly
Lowest at 5.14 times
in the last five half yearly periodsMOJO Watch
Company's pace of settling its Debtors has slowed
Debtors Turnover Ratio
Non Operating Income - Quarterly
Highest at Rs 13.02 cr
in the last five quartersMOJO Watch
Increased income from non business activities may not be sustainable
Non Operating Income






